Gentian Diagnostics ASA (GENT.OL)

NOK 39.0

(0.0%)

Total Liabilities Summary of Gentian Diagnostics ASA

Gentian Diagnostics ASA's latest annual total liabilities in 2023 was 33.65 Million NOK , up 0.1% from previous year.
Gentian Diagnostics ASA's latest quarterly total liabilities in 2024 Q3 was 27.64 Million NOK , down -6.24% from previous quarter.
Gentian Diagnostics ASA reported annual total liabilities of 33.62 Million NOK in 2022, down -9.19% from previous year.
Gentian Diagnostics ASA reported annual total liabilities of 37.02 Million NOK in 2021, down -9.0% from previous year.
Gentian Diagnostics ASA reported quarterly total liabilities of 27.64 Million NOK for 2024 Q3, down -6.24% from previous quarter.
Gentian Diagnostics ASA reported quarterly total liabilities of 35.17 Million NOK for 2024 Q1, up 4.51% from previous quarter.

Annual Total Liabilities Chart of Gentian Diagnostics ASA (2023 - 2013)

Historical Annual Total Liabilities of Gentian Diagnostics ASA (2023 - 2013)

Year	Total Liabilities	Total Liabilities Growth
2023	33.65 Million NOK	0.1%
2022	33.62 Million NOK	-9.19%
2021	37.02 Million NOK	-9.0%
2020	40.68 Million NOK	114.78%
2019	18.94 Million NOK	56.47%
2018	12.1 Million NOK	38.29%
2017	8.75 Million NOK	18.0%
2016	7.41 Million NOK	51.53%
2015	4.89 Million NOK	-58.78%
2014	11.87 Million NOK	-5.36%
2013	12.54 Million NOK	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q2	29.48 Million NOK	-16.16%
2024 Q3	27.64 Million NOK	-6.24%
2024 Q1	35.17 Million NOK	4.51%
2023 Q2	34.64 Million NOK	10.97%
2023 Q1	31.22 Million NOK	-7.13%
2023 Q4	33.65 Million NOK	3.94%
2023 FY	33.65 Million NOK	0.1%
2023 Q3	32.37 Million NOK	-6.56%
2022 Q3	32.75 Million NOK	-6.78%
2022 Q4	33.62 Million NOK	2.65%
2022 Q2	35.13 Million NOK	3.92%
2022 FY	33.62 Million NOK	-9.19%
2022 Q1	33.8 Million NOK	-8.68%
2021 Q2	45.63 Million NOK	25.57%
2021 FY	37.02 Million NOK	-9.0%
2021 Q1	36.34 Million NOK	-10.67%
2021 Q4	37.02 Million NOK	2.23%
2021 Q3	36.21 Million NOK	-20.64%
2020 Q2	15.79 Million NOK	-1.66%
2020 FY	40.68 Million NOK	114.78%
2020 Q3	17.15 Million NOK	8.6%
2020 Q4	40.68 Million NOK	137.22%
2020 Q1	16.06 Million NOK	-15.22%
2019 Q1	17.16 Million NOK	41.8%
2019 Q3	14.04 Million NOK	-4.81%
2019 Q2	14.75 Million NOK	-14.06%
2019 FY	18.94 Million NOK	56.47%
2019 Q4	18.94 Million NOK	34.88%
2018 Q4	12.1 Million NOK	25.04%
2018 Q2	8.91 Million NOK	-4.6%
2018 Q1	9.34 Million NOK	6.78%
2018 FY	12.1 Million NOK	38.29%
2018 Q3	9.68 Million NOK	8.57%
2017 FY	8.75 Million NOK	18.0%
2017 Q2	7.27 Million NOK	-5.19%
2017 Q4	8.75 Million NOK	29.58%
2017 Q3	6.75 Million NOK	-7.15%
2017 Q1	7.67 Million NOK	3.44%
2016 Q3	5.57 Million NOK	0.0%
2016 FY	7.41 Million NOK	51.53%
2016 Q4	7.41 Million NOK	33.07%
2015 Q4	4.89 Million NOK	0.0%
2015 FY	4.89 Million NOK	-58.78%
2014 FY	11.87 Million NOK	-5.36%
2013 FY	12.54 Million NOK	0.0%

Peer Total Liabilities Comparison of Gentian Diagnostics ASA

Name	Total Liabilities	Total Liabilities Difference
Lifecare AS	19.93 Million NOK	-68.816%
Medistim ASA	107.77 Million NOK	68.774%